Cargando…
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
SIMPLE SUMMARY: Cancer associated cachexia and loss of skeletal muscle mass is a negative prognostic marker for survival. Temporal muscle thickness (TMT) is an easily accessible parameter that has been suggested as a prognostic marker in glioblastoma. In this multicenter study we retrospectively ana...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615813/ https://www.ncbi.nlm.nih.gov/pubmed/34830766 http://dx.doi.org/10.3390/cancers13225610 |
_version_ | 1784604196375363584 |
---|---|
author | Wende, Tim Kasper, Johannes Prasse, Gordian Glass, Änne Kriesen, Thomas Freiman, Thomas M. Meixensberger, Jürgen Henker, Christian |
author_facet | Wende, Tim Kasper, Johannes Prasse, Gordian Glass, Änne Kriesen, Thomas Freiman, Thomas M. Meixensberger, Jürgen Henker, Christian |
author_sort | Wende, Tim |
collection | PubMed |
description | SIMPLE SUMMARY: Cancer associated cachexia and loss of skeletal muscle mass is a negative prognostic marker for survival. Temporal muscle thickness (TMT) is an easily accessible parameter that has been suggested as a prognostic marker in glioblastoma. In this multicenter study we retrospectively analyzed a cohort of 335 patients with newly diagnosed glioblastoma for their overall survival (OS) and TMT. Although previous studies found TMT to be an independent prognostic marker for OS, we could not reproduce these results. Instead, TMT seems to be a surrogate parameter for other epidemiological data. ABSTRACT: Background: Reduced temporal muscle thickness (TMT) has been discussed as a prognostic marker in IDH-wildtype glioblastoma. This retrospective multicenter study was designed to investigate whether TMT is an independent prognostic marker in newly diagnosed glioblastoma. Methods: TMT was retrospectively measured in 335 patients with newly diagnosed glioblastoma between 1 January 2014 and 31 December 2019 at the University Hospitals of Leipzig and Rostock. The cohort was dichotomized by TMT and tested for association with overall survival (OS) after 12 months by multivariate proportional hazard calculation. Results: TMT of 7.0 mm or more was associated with increased OS (46.3 ± 3.9% versus 36.6 ± 3.9%, p > 0.001). However, the sub-groups showed significant epidemiological differences. In multivariate proportional hazard calculation, patient age (HR 1.01; p = 0.004), MGMT promoter status (HR 0.76; p = 0.002), EOR (HR 0.61), adjuvant irradiation (HR 0.24) and adjuvant chemotherapy (HR 0.40; all p < 0.001) were independent prognostic markers for OS. However, KPS (HR 1.00, p = 0.31), BMI (HR 0.98, p = 0.11) and TMT (HR 1.06; p = 0.07) were not significantly associated with OS. Conclusion: TMT has not appeared as a statistically independent prognostic marker in this cohort of patients with newly diagnosed IDH-wildtype glioblastoma. |
format | Online Article Text |
id | pubmed-8615813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86158132021-11-26 Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis Wende, Tim Kasper, Johannes Prasse, Gordian Glass, Änne Kriesen, Thomas Freiman, Thomas M. Meixensberger, Jürgen Henker, Christian Cancers (Basel) Article SIMPLE SUMMARY: Cancer associated cachexia and loss of skeletal muscle mass is a negative prognostic marker for survival. Temporal muscle thickness (TMT) is an easily accessible parameter that has been suggested as a prognostic marker in glioblastoma. In this multicenter study we retrospectively analyzed a cohort of 335 patients with newly diagnosed glioblastoma for their overall survival (OS) and TMT. Although previous studies found TMT to be an independent prognostic marker for OS, we could not reproduce these results. Instead, TMT seems to be a surrogate parameter for other epidemiological data. ABSTRACT: Background: Reduced temporal muscle thickness (TMT) has been discussed as a prognostic marker in IDH-wildtype glioblastoma. This retrospective multicenter study was designed to investigate whether TMT is an independent prognostic marker in newly diagnosed glioblastoma. Methods: TMT was retrospectively measured in 335 patients with newly diagnosed glioblastoma between 1 January 2014 and 31 December 2019 at the University Hospitals of Leipzig and Rostock. The cohort was dichotomized by TMT and tested for association with overall survival (OS) after 12 months by multivariate proportional hazard calculation. Results: TMT of 7.0 mm or more was associated with increased OS (46.3 ± 3.9% versus 36.6 ± 3.9%, p > 0.001). However, the sub-groups showed significant epidemiological differences. In multivariate proportional hazard calculation, patient age (HR 1.01; p = 0.004), MGMT promoter status (HR 0.76; p = 0.002), EOR (HR 0.61), adjuvant irradiation (HR 0.24) and adjuvant chemotherapy (HR 0.40; all p < 0.001) were independent prognostic markers for OS. However, KPS (HR 1.00, p = 0.31), BMI (HR 0.98, p = 0.11) and TMT (HR 1.06; p = 0.07) were not significantly associated with OS. Conclusion: TMT has not appeared as a statistically independent prognostic marker in this cohort of patients with newly diagnosed IDH-wildtype glioblastoma. MDPI 2021-11-10 /pmc/articles/PMC8615813/ /pubmed/34830766 http://dx.doi.org/10.3390/cancers13225610 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wende, Tim Kasper, Johannes Prasse, Gordian Glass, Änne Kriesen, Thomas Freiman, Thomas M. Meixensberger, Jürgen Henker, Christian Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis |
title | Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis |
title_full | Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis |
title_fullStr | Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis |
title_full_unstemmed | Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis |
title_short | Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis |
title_sort | newly diagnosed idh-wildtype glioblastoma and temporal muscle thickness: a multicenter analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615813/ https://www.ncbi.nlm.nih.gov/pubmed/34830766 http://dx.doi.org/10.3390/cancers13225610 |
work_keys_str_mv | AT wendetim newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis AT kasperjohannes newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis AT prassegordian newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis AT glassanne newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis AT kriesenthomas newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis AT freimanthomasm newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis AT meixensbergerjurgen newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis AT henkerchristian newlydiagnosedidhwildtypeglioblastomaandtemporalmusclethicknessamulticenteranalysis |